An additional study was carried out in 2023 to investigate the serum levels of FGF2, IGF1, and VEGF in 40 children with ASD as the study group and 40 subjects with ASD and bipolar disorder (BD) as the control group. The gene discussed is FGF2; the disease is Behcet disease.